Your browser doesn't support javascript.
loading
Postmortem investigations and identification of multiple causes of child deaths: An analysis of findings from the Child Health and Mortality Prevention Surveillance (CHAMPS) network.
Breiman, Robert F; Blau, Dianna M; Mutevedzi, Portia; Akelo, Victor; Mandomando, Inacio; Ogbuanu, Ikechukwu U; Sow, Samba O; Madrid, Lola; El Arifeen, Shams; Garel, Mischka; Thwala, Nana Bukiwe; Onyango, Dickens; Sitoe, Antonio; Bassey, Ima-Abasi; Keita, Adama Mamby; Alemu, Addisu; Alam, Muntasir; Mahtab, Sana; Gethi, Dickson; Varo, Rosauro; Ojulong, Julius; Samura, Solomon; Mehta, Ashka; Ibrahim, Alexander M; Rahman, Afruna; Vitorino, Pio; Baillie, Vicky L; Agaya, Janet; Tapia, Milagritos D; Assefa, Nega; Chowdhury, Atique Iqbal; Scott, J Anthony G; Gurley, Emily S; Kotloff, Karen L; Jambai, Amara; Bassat, Quique; Tippett-Barr, Beth A; Madhi, Shabir A; Whitney, Cynthia G.
Afiliación
  • Breiman RF; Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America.
  • Blau DM; Emory Global Health Institute, Emory University, Atlanta, Georgia, United States of America.
  • Mutevedzi P; Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
  • Akelo V; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
  • Mandomando I; Department of Science and Innovation/National Research Foundation: Vaccine Preventable Diseases, University of the Witwatersrand Faculty of Health Sciences, Johannesburg, South Africa.
  • Ogbuanu IU; US Centers for Disease Control and Prevention-Kenya, Kisumu, Kenya.
  • Sow SO; Centro de Investigação em Saúde de Manhiça [CISM], Manhica, Mozambique.
  • Madrid L; Instituto Nacional de Saúde [INS], Manhiça, Mozambique.
  • El Arifeen S; Crown Agents, Freetown, Sierra Leone.
  • Garel M; Centre pour le Développement des Vaccins (CVD-Mali), Ministère de la Santé, Bamako, Mali.
  • Thwala NB; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
  • Onyango D; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom.
  • Sitoe A; College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
  • Bassey IA; International Center for Diarrhoeal Diseases Research (icddr,b), Dhaka, Bangladesh.
  • Keita AM; Emory Global Health Institute, Emory University, Atlanta, Georgia, United States of America.
  • Alemu A; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
  • Alam M; Department of Science and Innovation/National Research Foundation: Vaccine Preventable Diseases, University of the Witwatersrand Faculty of Health Sciences, Johannesburg, South Africa.
  • Mahtab S; Kisumu County, Kenya Department of Health, Kisumu, Kenya.
  • Gethi D; Centro de Investigação em Saúde de Manhiça [CISM], Manhica, Mozambique.
  • Varo R; ICAP-Columbia University, Makeni, Sierra Leone.
  • Ojulong J; Centre pour le Développement des Vaccins (CVD-Mali), Ministère de la Santé, Bamako, Mali.
  • Samura S; College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
  • Mehta A; International Center for Diarrhoeal Diseases Research (icddr,b), Dhaka, Bangladesh.
  • Ibrahim AM; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
  • Rahman A; Department of Science and Innovation/National Research Foundation: Vaccine Preventable Diseases, University of the Witwatersrand Faculty of Health Sciences, Johannesburg, South Africa.
  • Vitorino P; Kenya Medical Research Institute (KEMRI) Center for Global Health Research, Kisumu, Kenya.
  • Baillie VL; Centro de Investigação em Saúde de Manhiça [CISM], Manhica, Mozambique.
  • Agaya J; Universitat de Barcelona, Barcelona, Spain.
  • Tapia MD; ICAP-Columbia University, Makeni, Sierra Leone.
  • Assefa N; World Hope International, Makeni, Sierra Leone.
  • Chowdhury AI; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
  • Scott JAG; College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
  • Gurley ES; International Center for Diarrhoeal Diseases Research (icddr,b), Dhaka, Bangladesh.
  • Kotloff KL; Centro de Investigação em Saúde de Manhiça [CISM], Manhica, Mozambique.
  • Jambai A; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
  • Bassat Q; Kenya Medical Research Institute (KEMRI) Center for Global Health Research, Kisumu, Kenya.
  • Tippett-Barr BA; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
  • Madhi SA; College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
  • Whitney CG; International Center for Diarrhoeal Diseases Research (icddr,b), Dhaka, Bangladesh.
PLoS Med ; 18(9): e1003814, 2021 09.
Article en En | MEDLINE | ID: mdl-34591862
ABSTRACT

BACKGROUND:

The current burden of >5 million deaths yearly is the focus of the Sustainable Development Goal (SDG) to end preventable deaths of newborns and children under 5 years old by 2030. To accelerate progression toward this goal, data are needed that accurately quantify the leading causes of death, so that interventions can target the common causes. By adding postmortem pathology and microbiology studies to other available data, the Child Health and Mortality Prevention Surveillance (CHAMPS) network provides comprehensive evaluations of conditions leading to death, in contrast to standard methods that rely on data from medical records and verbal autopsy and report only a single underlying condition. We analyzed CHAMPS data to characterize the value of considering multiple causes of death. METHODS AND

FINDINGS:

We examined deaths identified from December 2016 through November 2020 from 7 CHAMPS sites (in Bangladesh, Ethiopia, Kenya, Mali, Mozambique, Sierra Leone, and South Africa), including 741 neonatal, 278 infant, and 241 child <5 years deaths for which results from Determination of Cause of Death (DeCoDe) panels were complete. DeCoDe panelists included all conditions in the causal chain according to the ICD-10 guidelines and assessed if prevention or effective management of the condition would have prevented the death. We analyzed the distribution of all conditions listed as causal, including underlying, antecedent, and immediate causes of death. Among 1,232 deaths with an underlying condition determined, we found a range of 0 to 6 (mean 1.5, IQR 0 to 2) additional conditions in the causal chain leading to death. While pathology provides very helpful clues, we cannot always be certain that conditions identified led to death or occurred in an agonal stage of death. For neonates, preterm birth complications (most commonly respiratory distress syndrome) were the most common underlying condition (n = 282, 38%); among those with preterm birth complications, 256 (91%) had additional conditions in causal chains, including 184 (65%) with a different preterm birth complication, 128 (45%) with neonatal sepsis, 69 (24%) with lower respiratory infection (LRI), 60 (21%) with meningitis, and 25 (9%) with perinatal asphyxia/hypoxia. Of the 278 infant deaths, 212 (79%) had ≥1 additional cause of death (CoD) beyond the underlying cause. The 2 most common underlying conditions in infants were malnutrition and congenital birth defects; LRI and sepsis were the most common additional conditions in causal chains, each accounting for approximately half of deaths with either underlying condition. Of the 241 child deaths, 178 (75%) had ≥1 additional condition. Among 46 child deaths with malnutrition as the underlying condition, all had ≥1 other condition in the causal chain, most commonly sepsis, followed by LRI, malaria, and diarrheal disease. Including all positions in the causal chain for neonatal deaths resulted in 19-fold and 11-fold increases in attributable roles for meningitis and LRI, respectively. For infant deaths, the proportion caused by meningitis and sepsis increased by 16-fold and 11-fold, respectively; for child deaths, sepsis and LRI are increased 12-fold and 10-fold, respectively. While comprehensive CoD determinations were done for a substantial number of deaths, there is potential for bias regarding which deaths in surveillance areas underwent minimally invasive tissue sampling (MITS), potentially reducing representativeness of findings.

CONCLUSIONS:

Including conditions that appear anywhere in the causal chain, rather than considering underlying condition alone, markedly changed the proportion of deaths attributed to various diagnoses, especially LRI, sepsis, and meningitis. While CHAMPS methods cannot determine when 2 conditions cause death independently or may be synergistic, our findings suggest that considering the chain of events leading to death can better guide research and prevention priorities aimed at reducing child deaths.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mortalidad Infantil / Salud Infantil / Causas de Muerte / Mortalidad del Niño / Salud del Lactante Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Child, preschool / Female / Humans / Infant / Male / Newborn País/Región como asunto: Africa / Asia Idioma: En Revista: PLoS Med Asunto de la revista: MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mortalidad Infantil / Salud Infantil / Causas de Muerte / Mortalidad del Niño / Salud del Lactante Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Child, preschool / Female / Humans / Infant / Male / Newborn País/Región como asunto: Africa / Asia Idioma: En Revista: PLoS Med Asunto de la revista: MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos